News
Already thriving with a successful launch of infused Vyvgart and its subcutaneous follow-on Vyvgart ... has signed off on argenx’s prefilled syringe (PFS) version of Vyvgart Hytrulo, which ...
The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster immune disorder drug, Vyvgart, giving patients a more convenient option of ...
VYVGART ® Hytrulo prefilled syringe for self-injection is approved as a 20-to-30-second subcutaneous injection administered by a patient, caregiver, or healthcare professional. Patients are able ...
Hosted on MSN1mon
US FDA approves syringe version of Argenx's immune disorder drugArgenx said the Vyvgart Hytrulo prefilled syringe will be available within the next two weeks and that it would have a comparable price to the subcutaneous vial. "The new version is going to make ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results